Ovarian Serous Borderline Tumor

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-09-29
Clinical Trial Update: Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer [Phase 2, Phase 3]
Clinical trial update on trametinib for recurrent or progressive low-grade ovarian cancer and peritoneal serous cancers (Phase 2/Phase 3) wi…